Immuneering (IMRX) Assets Average (2021 - 2024)
Historic Assets Average for Immuneering (IMRX) over the last 4 years, with Q3 2024 value amounting to $72.8 million.
- Immuneering's Assets Average fell 3900.38% to $72.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $72.8 million, marking a year-over-year decrease of 3900.38%. This contributed to the annual value of $112.5 million for FY2023, which is 2218.14% down from last year.
- Per Immuneering's latest filing, its Assets Average stood at $72.8 million for Q3 2024, which was down 3900.38% from $82.5 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Assets Average registered a high of $165.4 million during Q4 2021, and its lowest value of $72.8 million during Q3 2024.
- Over the past 4 years, Immuneering's median Assets Average value was $116.3 million (recorded in 2023), while the average stood at $119.7 million.
- Its Assets Average has fluctuated over the past 5 years, first soared by 2702.04% in 2022, then tumbled by 3900.38% in 2024.
- Quarter analysis of 4 years shows Immuneering's Assets Average stood at $165.4 million in 2021, then decreased by 22.58% to $128.0 million in 2022, then decreased by 15.46% to $108.2 million in 2023, then plummeted by 32.72% to $72.8 million in 2024.
- Its Assets Average stands at $72.8 million for Q3 2024, versus $82.5 million for Q2 2024 and $95.3 million for Q1 2024.